Article Information
History
- February 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Deborah L. Stone1,
- Amanda Ombrello1,
- Juan I. Arostegui2,
- Corinne Schneider3,
- Adriana de Jesus4,
- Charlotte Girard-Guyonvarc’h5,
- Cem Gabay5,
- Wonyong Lee1,
- Jae Jin Chae1,
- Ivona Aksentijevich1,
- Raphaela Goldbach-Mansky4,
- Daniel L. Kastner1 and
- Scott W. Canna3,#
- 1Inflammatory Disease Section, Intramural Research Program, NHGRI
- 2Department of Immunology, Hospital Clinic; Institut d’Investigacions Biomédiques August Pi i Sunyer, Barcelona, Spain
- 3University of Pittsburgh/UPMC Children’s Hospital of Pittsburgh
- 4Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology, Intramural Research Program, NIAID
- 5Division of Rheumatology, Department of Medicine, University Hospital of Geneva and Faculty of Medicine University of Geneva, Geneva, Switzerland
- ↵#Address Correspondence to: Scott W. Canna, 8124 Rangos Bldg, 530 45th St, Pittsburgh, PA 15201, Ph: 412.692.9934, Fax: 412.692.5054, Scott.canna{at}chp.edu
Posted February 23, 2021.
Excess Serum Interleukin-18 Distinguishes Patients with Pathogenic Mutations in PSTPIP1
